Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.7%

3 terminated/withdrawn out of 448 trials

Success Rate

96.6%

+10.0% vs industry average

Late-Stage Pipeline

13%

59 trials in Phase 3/4

Results Transparency

1%

1 of 84 completed trials have results

Key Signals

127 recruiting1 with results

Enrollment Performance

Analytics

N/A
131(44.1%)
Phase 2
74(24.9%)
Phase 3
33(11.1%)
Phase 1
30(10.1%)
Phase 4
26(8.8%)
Early Phase 1
3(1.0%)
297Total
N/A(131)
Phase 2(74)
Phase 3(33)
Phase 1(30)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (448)

Showing 20 of 448 trials
NCT07854002Not Yet Recruiting

Multimodal Risk Factor Graph Mapping, Metabolic Subtyping, and Digital Intelligent Chronic Disease Management for Prediabetes: An Integrated Cohort and Case-Control Clinical Study

Role: collaborator

NCT06742125Not ApplicableRecruiting

Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial Infarction

Role: collaborator

NCT06238232Not ApplicableCompleted

68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Primary Aldosteronism: The GAPA Randomized Clinical Trial

Role: collaborator

NCT07643922Not ApplicableNot Yet Recruiting

Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage

Role: collaborator

NCT07744659Not ApplicableRecruiting

Spinal Cord Stimulation for Poststroke Spasticity

Role: collaborator

NCT07828873Phase 2Not Yet Recruiting

A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ Adenocarcinoma

Role: lead

NCT07814859Phase 2Not Yet Recruiting

Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer

Role: lead

NCT06358209Not ApplicableRecruiting

Safety and Efficacy of Ventricular Irrigation for Ventriculitis

Role: collaborator

NCT07811895Not ApplicableNot Yet Recruiting

Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

Role: collaborator

NCT07127484Not ApplicableRecruiting

Hemoadsorption for Severe Ischemic Stroke

Role: collaborator

NCT07182188Not ApplicableActive Not Recruiting

A Clinical Trial of Vascular Interventional Robotic System for Cerebral Angiography

Role: collaborator

NCT07183878Not ApplicableRecruiting

Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)

Role: collaborator

NCT07003737Not ApplicableRecruiting

Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT07294664Phase 2Recruiting

PDL1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer

Role: lead

NCT07794514Not ApplicableRecruiting

Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD

Role: collaborator

NCT05168280Not ApplicableCompleted

Intraoperative Infusion of Dexmedetomidine for Prevention of Postoperative Delirium in Elderly Patients

Role: collaborator

NCT07347990Not ApplicableRecruiting

Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy

Role: collaborator

NCT06198517Not ApplicableCompleted

Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT

Role: collaborator

NCT07774143Not ApplicableRecruiting

A Prospective, Multicenter, Randomized Controlled Trial Investigating the Impact of Fasting Duration on Postoperative Rebleeding Following Esophageal Variceal Ligation.

Role: lead

NCT07770113Phase 2Recruiting

A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric Cancer

Role: lead